Latest filing published 02 Feb 2026 for ZEVRA THERAPEUTICS, INC., €33k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Adrian W. Quartel: trading record in brief
This profile gathers the share dealings of Adrian W. Quartel in Zevra Therapeutics, Inc. We count 2 filings, every one of them for a trade on 30 January 2026.
No open-market purchase appears, only 1 sale worth €33k. Other entries cover 1 option exercise.
The newest entry dates from 2 February 2026: an open-market sale of €33k, in Zevra Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Adrian W. Quartel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,533 shares@ US$8.83100.0% of flowCommon StockSEC:0001910132-26-000002:1
- 11,333 sharesCommon StockSEC:0001910132-26-000002:0
2 of 2 declarations